95,349 results match your criteria: "Comprehensive Cancer Center[Affiliation]"
Ann Intern Med
September 2025
Department of Medicine, Indiana University School of Medicine; Indiana University Melvin and Bren Simon Comprehensive Cancer Center; and Regenstrief Institute, Inc., Indianapolis, Indiana (T.F.I.).
Background: Providing personalized risk information to patients and their providers could improve colorectal cancer (CRC) screening.
Objective: To determine whether providing information on patient risk for advanced colorectal neoplasia (ACN; which includes CRC and advanced precancerous lesions) to patients and providers affects screening uptake, and to identify effect moderators.
Design: Randomized controlled trial (2 × 2 factorial design).
Cancer Immunol Res
September 2025
Tianjin Medical University General Hospital, Tianjin, China.
Combination chemotherapy and immunotherapy are effective against advanced gastric cancer (GC). However, T cell exhaustion in the tumor microenvironment may decrease the immune response and compromise the effectiveness of immunotherapy. Herein, we report the potential role of EBI3 in promoting T cell exhaustion and its mechanism in GC, showing high expression of EBI3 in GC.
View Article and Find Full Text PDFMol Diagn Ther
September 2025
Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Background: Recurrent gastric or gastroesophageal junction cancers have poor prognoses and limited treatment options. While archival tumor tissue is commonly used for genomic profiling, it may not reflect molecular changes at recurrence.
Objective: We aimed to assess the utility of a circulating tumor DNA analysis in identifying actionable genomic alterations at recurrence and compare findings with archival primary tumor profiles.
World J Urol
September 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
J Math Biol
September 2025
Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, 01609, MA, USA.
It is widely recognized that reciprocal interactions between cells and their microenvironment, via mechanical forces and biochemical signaling pathways, regulate cell behaviors during normal development, homeostasis and disease progression such as cancer. However, how exactly cells and tissues regulate growth in response to chemical and mechanical cues is still not clear. Here, we propose a framework for the chemomechanical regulation of growth based on thermodynamics of continua and growth-elasticity to predict growth patterns.
View Article and Find Full Text PDFCurr Treat Options Oncol
September 2025
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) are among the most common adult soft tissue sarcoma (STS) subtypes. Due to their high genetic complexity, heterogeneity, and lack of specific genetic alterations, no consistent molecular targets for targeted therapy have been identified for UPS and MFS. Recently, immune checkpoint inhibition (ICI) has emerged as a promising treatment modality for UPS and MFS.
View Article and Find Full Text PDFPediatr Blood Cancer
September 2025
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
Background: Screening for financial hardship and health-related social needs (HRSN) in pediatric oncology is recommended, yet practices vary widely, and standardized implementation remains limited. We implemented systematic screening in a pediatric oncology clinic in New York City.
Procedure: We evaluated the implementation of financial hardship (two items) and HRSN (difficulty affording food, housing, transportation, eight items) screening in outpatient pediatric oncology clinic.
Math Med Biol
September 2025
Department of Mathematics, Florida State University, 1017 Academic Way, 32306, FL, USA.
We propose a system of ordinary differential equations to model the mouse immune response of two key immune cell types (CD4+ and CD8+ cells) to an established triple-negative breast cancer tumor while being treated with immunotherapy drugs of anti-PD-1 and anti-CTLA-4 immune checkpoint inhibitors. The model incorporates longitudinal positron emission tomography image data from a series of experiments where immunotherapy treatment was given in combination or separately. Control data optimization estimates the immune-tumor response of a general mouse burdened with breast cancer.
View Article and Find Full Text PDFFuture Oncol
September 2025
oInstitut de Cancérologie Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Neuro Oncol
August 2025
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Background: The WHO 2021 classification criteria for adult diffuse glioma integrate histology with molecular profiling for conclusive diagnosis. Since molecular profiling can be expensive and time-consuming, often necessitating outsourcing or leading to the 'not otherwise specified (NOS) label', this study develops an AI-driven WHO 2021 classification of gliomas solely from H&E whole-slide images (WSIs).
Methods: Our pipeline is based on a multi-institutional dataset reclassified per WHO 2021 guidelines.
Ophthalmic Genet
August 2025
The Vision Center and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA.
Background: Optic nerve hypoplasia (ONH), the leading congenital cause of permanent blindness, is characterized by a retinal ganglion cell (RGC) deficit at birth and frequently associated neurologic and endocrine abnormalities. Multifactorial developmental events are hypothesized to underlie ONH; however, environmental influences are unclear, and genetic causes are under-investigated.
Methods: To identify monogenic, disease-causing variants among ONH patients, exomes from 34 ONH subjects and their parents were sequenced and rare variants identified.
Br J Haematol
August 2025
Department of Pediatric Oncology, National Cancer Institute Cairo University, Cairo, Egypt.
Juvenile myelomonocytic leukaemia (JMML) is a rare haematological malignancy caused by mutations in the Ras signalling pathway. Next-generation sequencing (NGS) and DNA methylation profiling used for diagnostic and risk stratification purposes are now standard of care in Europe and the United States for patients with JMML. To better understand how implementing these types of technologies would impact the treatment of JMML patients in different settings, molecular profiling was performed on 81 patients treated for JMML in Egypt from 2009 to 2022.
View Article and Find Full Text PDFMethods Enzymol
August 2025
Department of Biochemistry, Case Western Reserve University, Cleveland, OH, United States; School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States. Electronic address:
ATE1 is an enzyme that catalyzes the post-translational arginylation of proteins by transferring arginine to acidic residues, such as aspartate and glutamate, located at the N-terminus or on side chains. This modification plays important roles in regulating protein stability and function. The mechanisms underlying substrate and site selection by ATE1 remain unclear.
View Article and Find Full Text PDFMethods Enzymol
August 2025
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH, United States; School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States. Electronic address:
This chapter presents a straightforward method for expressing and purifying recombinant human Arginyl-tRNA-protein transferase 1 (ATE1) from E. coli. ATE1 is an enzyme that catalyzes the transfer of arginine from arginyl-tRNA to the N-terminal or internal Asp or Glu residues of the substrate proteins, a process that regulates protein turnover or function.
View Article and Find Full Text PDFJ Microbiol Methods
August 2025
Department of Human Sciences & James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Electronic address:
Metaproteomic analysis offers critical insights into gut microbiome function; however, efficient microbial protein extraction from fecal samples remains challenging due to the complexity of different types of bacterial cell walls in the microbiome. In this study, we systematically compared three representative detergent-based lysis buffers (sodium dodecyl sulfate_urea, dodecyl β-D-maltoside_urea, sodium dodecyl sulfate_ dodecyl β-D-maltoside_urea) for metaproteomics sample preparation. After multiple levels of analyses, we identified SDS_DDM_urea as the most efficient option for extracting diverse microbial proteins, peptides, and identifying microbial species.
View Article and Find Full Text PDFHum Pathol
August 2025
Departments of Pathology, The International Peace Maternal and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China; Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, 200030, China. Electronic address:
Context: Pilomatrix-like high-grade endometrioid carcinoma (PiMHEC) represents a recently described, aggressive variant of endometrial carcinoma. Prior reports have linked PiMHEC with CTNNB1 exon 3 mutations and abnormal nuclear β-catenin expression.
Objective: We aimed to expand the understanding a potential subclassification of PiMHEC by analyzing three new cases that lack CTNNB1 mutations and β-catenin nuclear accumulation.
J Exp Clin Cancer Res
August 2025
Institute for Genome Sciences, University of Maryland School of Medicine, 670 West Baltimore Street, Baltimore, MD, 21201, USA.
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer globally and presents a persistent clinical challenge due to the limited availability of effective targeted therapeutics. Recent studies have identified the ubiquitin-associated and SH3 domain-containing B (UBASH3B), a tyrosine phosphatase, as a key oncogenic player in HNSCC pathogenesis. Elevated UBASH3B expression correlates with poor clinical outcomes in HNSCC patients.
View Article and Find Full Text PDFSignal Transduct Target Ther
August 2025
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Essen, Essen, University of Duisburg-Essen, Essen, 45147, Germany.
Neutrophils have emerged as key players in tumor progression and are often associated with poor prognosis. Despite ongoing efforts to target neutrophil functions in cancer, therapeutic success has been limited. In this study, we addressed the possibility of blocking STAT3 signaling in neutrophils as a targeted therapeutic intervention in cancer.
View Article and Find Full Text PDFJ Manag Care Spec Pharm
September 2025
Division of Medical Oncology, Department of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles.
Background: Alectinib, brigatinib, and lorlatinib are all preferred first-line (1L) therapies for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in National Comprehensive Cancer Network (NCCN) guidelines. Although clinical trials have demonstrated their efficacy, real-world evidence on treatment patterns, costs, and outcomes may help differentiate these therapies and inform optimal 1L treatment selection in the absence of head-to-head comparisons.
Objective: To evaluate real-world outcomes for patients with ALK+ NSCLC receiving 1L ALK tyrosine kinase inhibitors (TKIs), focusing on drug acquisition costs, health care utilization, and clinical outcomes.
J Exp Clin Cancer Res
August 2025
Department of Cancer Biology and Genetics, College of Medicine, Arthur G. James Comprehensive Cancer Center (OSUCCC), The Ohio State Universityand, Columbus, OH, USA.
Background: RANBP9 and RANBP10, also called Scorpins, are essential components of the C-terminal to LisH (CTLH) complex, an evolutionarily conserved poorly investigated multisubunit E3 ligase. Their role in non-small cell lung cancer (NSCLC) is unknown.
Methods: In this study, first we used stable loss-of function and overexpression inducible cell lines to investigate the ability of either RANBP9 or RANBP10 to form their own functional CTLH complex.
Nat Synth
January 2025
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
The application of molecular imaging has advanced personalized medicine and generated a profound impact on patient care. Positron emission tomography and magnetic resonance imaging are among the most widely used imaging modalities, often requiring the isotopic labelling of bioactive molecules to generate the desired imaging probes. Unfortunately, radiochemistry often limits the development of novel agents due to complicated syntheses and the incompatibility of complex molecules.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Planta
August 2025
Department of Plant and Soil Science, Davis College of Agricultural Sciences and Natural Resources, Texas Tech University, Lubbock, TX, USA.
Understanding the nature of non-parental phenotypes created by transgressive segregation is important in creating novel genetic recombinants that can withstand different environmental conditions for crop production. FL510, a transgressive salinity-tolerant rice genotype from a cross between IR29 (salt-sensitive) and Pokkali (salt-tolerant), has tolerance mechanisms active under control conditions and improves survival upon the onset of salinity. This study compares normal-state metabolomes and lipidomes of FL510 with its parents.
View Article and Find Full Text PDFNPJ Digit Med
August 2025
Department of Surgery, City of Hope, Duarte, CA, USA.
This randomized trial compared remote perioperative telemonitoring (RPM) care versus surgeon only care in patients with gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancers (N = 293). The RPM care arm wore a wristband accelerometer and reported symptoms via a mobile application (app) before surgery and at days 7, 14, 30, 60, 90 post-discharge. Triage nurses telephoned patients when data deviated from predetermined thresholds.
View Article and Find Full Text PDFViruses
August 2025
State Key Laboratory of Virology and Biosafety, Department of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
Persistent type I interferon (IFN-I) signaling compromises adaptive anti-HIV-1 T cell immunity and promotes viral reservoir persistence, yet its effects on innate lymphoid cells during chronic infection remain unclear. Through integrated single-cell RNA sequencing and functional validation in HIV-1-infected humanized mice with combination antiretroviral therapy (cART) and IFN-I signaling blockade, we reveal IFN-I-induced dysfunction of natural killer (NK) cells and group 3 innate lymphoid cells (ILC3s). Mechanistically, the IFN-I-CD9 axis drives NK cells toward a decidual NK cell-like phenotype, impairing their cytotoxic activity.
View Article and Find Full Text PDF